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Tri-organotin(IV) complexes of the triazolo-pyrimidine derivatives 4,5-dihydro-5-oxo-[1,2,4]triazolo-[1,5a]pyrimidine (5HtpO),
4,7-dihydro-5-methyl-7-oxo-[1,2,4]triazolo-[1,5a]pyrimidine (HmtpO), and 4,5,6,7-tetrahydro-5,7-dioxo-[1,2,4]triazolo-[1,5a]pyrimi-
dine (H2tpO2), and the diorganotin derivative n-Bu2Sn(tpO2), were synthesized and characterized by means of infrared and
119Sn
Mo¨ssbauer spectroscopy. In all the complexes obtained the triazolopyrimidines act as multidentate ligands producing polymeric
structures.
A trigonal bipyramidal arrangement of the ligands around the tin atom is proposed for triorganotin(IV) derivatives, with organic
groups on the equatorial plane and bridging anionic ligands.
DFT calculations were performed on the structure of H2tpO2 and on its mono- an di-anions, to investigate their harmonic vibra-
tional modes. The observed trend of the experimental and calculated carbonyl stretching frequencies furnishes a support for the
interpretation of the structure of the organotin(IV) complexes obtained with this ligand.
The structure of n-Bu2Sn(tpO2) was elucidated by quantum chemical calculations, performed on a model system of the polymeric
complex by a two layers ONIOM method. The combined experimental and theoretical results obtained support for a trans-n-Bu2
distorted octahedral geometry, with the tpO22 units acting as bis-chelate ligands bridging the diorganotin(IV) moieties, and with the
N(1)O(7) and N(4)O(5) chelating groups in the equatorial plane showing a cis-O2, or cis-N2, coordination.
In vitro antimicrobial tests were performed on n-Bu3Sn(HtpO2) and Ph3Sn(HtpO2), and a good antifungal and antibioﬁlm activ-
ity was observed, in particular for n-Bu3Sn(HtpO2).
 2005 Elsevier B.V. All rights reserved.
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The coordination chemistry of heterocyclic ligands is
a ﬁeld of increasing interest. Between them, 1,2,4-tri-
azole-[1,5-a]pyrimidine (tp) derivatives are particularly
studied because they are isomers of purines, and their0022-328X/$ - see front matter  2005 Elsevier B.V. All rights reserved.
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E-mail address: gruisi@unipa.it (G. Ruisi).coordination compounds can be considered as model
systems for metal–ligand interactions observed in bio-
logical systems [1]. Triazolopyrimidines are versatile li-
gands for metal ions, the resulting complexes giving
rise to a variety of structures including homo- and het-
ero-polynuclear compounds [1,2]. Further interest in
the ﬁeld comes from the search of new compounds with
antimicrobial activity [1]. Many transition metal com-
plexes of triazolopyrimidines were so far studied, while
Fig. 1. The more stable tautomeric forms of the ligands employed and
the atom numbering scheme.
Table 1
119Sn Mo¨ssbauer parameters of organotin(IV) complexes in the solid
statea
Compound db (mm s1) DEc (mm s1) Cd (mm s1)
Me3Sn(5tpO) (1) 1.28 3.42 0.81
n-Bu3Sn(5tpO) (2) 1.40 3.47 0.86
Me3Sn(mtpO) (3) 1.30 3.42 0.90
n-Bu3Sn(mtpO) (4) 1.44 3.63 0.91
n-Bu3Sn(HtpO2) (5) 1.48 3.90 0.87
Ph3Sn(HtpO2) (6) 1.28 3.35 0.92
n-Bu2Sn(tpO2) (7) 1.54 4.43 0.89
a At liquid-nitrogen temperature.
b Isomer shift with respect to room-temperature CaSnO3.
c Nuclear quadrupole splitting.
d Full-width at half-height of the resonant peaks.
4774 M.A. Girasolo et al. / Journal of Organometallic Chemistry 690 (2005) 4773–4783no work has been reported, to our knowledge, on
their organotin(IV) derivatives, despite the ascertained
biocide properties of organotin(IV) compounds [3].
Here, we report on the synthesis and spectroscopic
characterization of R3Sn(IV) (R = Me, n-Bu, Ph)
and n-Bu2-Sn(IV) complexes of 4,5-dihydro-5-oxo-[1,
2,4]triazolo-[1,5a]pyrimidine (5HtpO), 4,7-dihydro-5-
methyl-7-oxo-[1,2,4]triazolo-[1,5a]pyrimidine (HmtpO),
and 4,5,6,7-tetrahydro-5,7-dioxo-[1,2,4]triazolo-[1,5a]-
pyrimidine (H2tpO2), see Fig. 1.
We also report on in vitro antimicrobial tests per-
formed on n-Bu3Sn(HtpO2) and Ph3Sn(HtpO2).
The presence of oxygen heteroatoms furnishes inter-
esting properties to the oxo-derivatives of tp, in particu-
lar it improves: (i) their acidic strength and (ii) the
coordination capability of the nitrogen atom N(4), even
in the molecular ligands by keto-enolic tautomerism [4].2. Experimental
2.1. Materials and methods
The products employed in the present study were ob-
tained from C. Erba (Milan, Italy) and Sigma–Aldrich
(Milan, Italy), unless otherwise stated, and used without
further puriﬁcation except methanol, which was distilled
over magnesium. The ligands 5HtpO and H2tpO2 were
synthesized as previously reported [5,6].
Carbon, hydrogen and nitrogen assays were carried
out with a Vario EL III elemental analyzer (Elementar
GmbH, Germany).
The Mo¨ssbauer (nuclear c resonance) spectrometers,
the related instrumentation and data reduction proce-
dures were as previously described [7]. A 10 mCi Ca119S-
nO3 source (RITVERC GmbH, St. Petersburg, Russia)
was employed. The isomer shifts are relative to room
temperature Ca119SnO3. Solution samples were quickly
frozen by immersion in liquid nitrogen in order to ob-
tain glassy absorbers. The 119Sn Mo¨ssbauer parameters
are reported in Tables 1 and 2.
13C NMR spectra were recorded at 63 MHz with a
Bruker AC 250 E instrument. Spectral data are reported
in Table 2.
Infrared spectra (nujol and hexachlorobutadiene
mulls, CsI windows) were recorded with an FT-IR spec-trometer Perkin–Elmer Spectrum One. Selected bands
are reported in Table 3.
2.2. Synthesis of the complexes
The complexes were obtained by reacting the proper
organotin compound (2 mmol) with the triazolo-pyrim-
idine derivative (2 mmol) in methanol (20 mL), as below
speciﬁed.
[Me3Sn(5tpO)] (1): Me3SnOH + 5HtpO; the solution
was reﬂuxed for 3 h, and left at RT overnight. A white
solid precipitated, which was ﬁltered oﬀ, washed and
dried in vacuo. m.p. 225–226 C. Anal. Calc. for
C8H12N4OSn (298.921 g mol
1) C, 32.15; H, 4.05; N,
18.74. Found: C, 32.98; H, 3.89; N, 18.20%.
[n-Bu3Sn(5tpO)] (2): n-Bu3SnOCH3 + 5HtpO; the
solution was reﬂuxed for 3 h, then concentrated by evap-
oration of the solvent in vacuo. An oil was obtained
which gave a white crystalline product by treatment with
petroleum ether (40–60 C). m.p. 105–108 C. Anal.
Calc. for C17H30N4OSn (425.164 g mol
1) C, 48.03; H,
7.11; N, 13.18. Found: C, 47.69; H, 7.14; N, 12.63%.
[Me3Sn(mtpO)] (3): Me3SnOH + HmtpO; the solu-
tion was reﬂuxed for 1 h, then concentrated in vacuo.
A white solid product was obtained which was ﬁltered
oﬀ and dried in vacuo. m.p. 270–273 C. Anal. Calc.
for C9H14N4OSn (312.948 g mol
1) C, 34.54; H, 4.51;
N, 17.90. Found: C, 33.98; H, 4.24; N, 18.50%.
[n-Bu3Sn(mtpO)] (4): n-Bu3SnOCH3 + HmtpO; the
solution was stirred for 1 h, then concentrated in vacuo.
A white solid product was obtained which was ﬁltered
oﬀ and dried in vacuo. The product is pasty at room tem-
perature. m.p. 93-94 C. Anal. Calc. for C18H32N4OSn
(439.191 g mol1) C, 49.23; H, 7.34; N, 12.76. Found:
C, 49.09; H, 7.98; N, 12.87%.
[n-Bu3Sn(HtpO2)] (5): n-Bu3SnOCH3 + H2pO2; the
solution was reﬂuxed for 1 h, then concentrated in
vacuo. An oil was obtained which gave a white solid
product when dried in vacuo. m.p. 164–166 C. Anal.
Calc. for C17H29N4O2Sn (441.164 g mol
1) C, 46.28;
H, 6.85; N, 12.70; C, 45.94; H, 7.09; N, 12.82.
Table 2
Solution phase spectroscopic data of triorganotin(IV) derivatives of H2tpO2
13C NMRa C(6) C(2) C(3a) C(7) C(5) Sn–R
n-Bu3Sn(HtpO2) 81.86 151.0 151.2 160.9 167.7 19.0(a-CH2); 28.8(b-CH2); 28.0(c-CH2); 13.9(CH3); j1J(13C–119Sn)j = 454.5 Hz
119Sn Mo¨ssbauerb dc (mm s1) DEd (mm s1) Ce (mm s1)
n-Bu3Sn(HtpO2) in CH3OH
f 1.44 3.81 0.80
n-Bu3Sn(HtpO2) in CH3OH/H2O 2:1
f 1.45 3.89 0.78
Ph3Sn(HtpO2) in CH3OH
g 1.26 3.29 0.85
a in CD3OD; d in ppm from internal TMS.
b Frozen solutions at liquid-nitrogen temperature.
c Isomer shift with respect to room-temperature CaSnO3.
d Nuclear quadrupole splitting.
e Full-width at half-height of the resonant peaks.
f 0.1 M solution.
g Saturated solution.
Table 3
Selected IR bands (cm1) for organotin(IV) complexes and ligands
Compound m(C@O) m(Sn–C)
5HtpO 1737s; 1683s,b
1 Me3Sn(5tpO)
a 1627vs 557s
2 n-Bu3Sn(5tpO) 1627vs
HmtpO 1702vs
3 Me3Sn(mtpO)
b 1620s 546s
4 n-Bu3Sn(mtpO) 1633vs
H2tpO2 1715s
HtpO2 1679vs
tpO22 1644s
5 n-Bu3Sn(HtpO2) 1654vs
6 Ph3Sn(HtpO2)
c 1661s
7 n-Bu2Sn(tpO2) 1629vs
a q(CH3) = 774s.
b q(CH3) = 775s.
c Phenyl group vibrations [35]: 1481m, m(C–C); 1430 m, m(C–C); 1078
m, b(C–H); 727s, c(C–H); 697s, c(C–H). Abbreviations: vs, very
strong; s, strong; b, broad.
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tion was reﬂuxed for 2 h, then concentrated in vacuo.
A viscous product was obtained which gave a white so-
lid product when dried under vacuum. m.p. 292 C
(dec). Anal. Calc. for C23H18N4O2Sn (501.135 g mol
1)
C, 55.13; H, 3.62; N, 11.18. Found: C, 54.74; H, 3.79; N,
10.57%.
[n-Bu2Sn(tpO2)2] (7) was obtained by reﬂuxing a mix-
ture of H2tpO2 and n-Bu2SnO (in both 1:1 and 2:1 ra-
tios), or n-Bu2Sn(OMe)2 (1:1 ratio) for 3 h. The solid
white product was then ﬁltered and dried in vacuo.
m.p. 300 C (dec). Anal. Calc. for C13H20N4O2Sn
(383.040 g mol1) C, 40.77; H, 5.26; N, 14.63. Found:
C, 40.83; H, 5.27; N, 14.34%.
2.3. Antimicrobial activity
2.3.1. Microorganisms
The microbial strains used were Escherichia coli
ATCC 25922, Pseudomonas aeruginosa ATCC 9027,Staphylococcus aureus ATCC 25923, Staphylococcus epi-
dermidis DSM 3269, Candida albicans ATCC 10231 and
Candida tropicalis ATCC 13803.2.3.2. Antibacterial activity
2.3.2.1. Determination of the minimum inhibitory concen-
trations (MICs) by broth dilution micro-method. A ser-
ies of solutions with a range of concentrations from
100 to 0.37 lg/mL (obtained by twofold serial dilu-
tion) was prepared. The serial dilutions were made in
Mueller Hinton broth (Merck KGaA, Germany) in a
96-wells plate starting from a stock solution of 10
mg/mL in ethanol. To each well 10 lL of a bacterial
suspension, obtained from a 24 h culture, containing
106 cfu/mL was added [8]. The plate was incubated
at 37 C for 24 h; after this time the MICs were deter-
mined, by a microplate reader (ELX 800, Bio-Tek
Instruments), as the lowest concentration of the com-
pound whose optical density, read at 570 nm, was
comparable to the negative control wells (broth only,
without inoculum). For comparative purpose and
quality control of the method we tested the antibiotic
amikacin.2.3.3. Antifungal activity
2.3.3.1. Determination of MICs by broth dilution. A
series of solutions of each substance with a range of con-
centrations from 100 to 0.37 lg/mL (obtained by two-
fold serial dilution) was prepared in Sabouraud
dextrose broth, using a stock solution of 10 mg/mL in
ethanol. The test tubes were seeded using a fungal sus-
pension containing 105 cfu/mL. The microbial cultures
were incubated at 37 C for 24 h. The lowest concentra-
tion of substance which completely inhibited the growth
of the test organism when compared with the growth of
a drug-free control, but added with maximum volume of
solvent, was considered the MIC. Amphotericin B was
used for comparative purpose and quality control of
the method.
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Sabouraud dextrose broth containing 20% foetal bo-
vine serum was used as medium in germ tube formation
assay. 1 mL of a fungal suspension in 0.9% NaCl,
whose transmittance at 570 nm was about 15%, was
seeded in the medium described before, supplemented
with several concentrations ranging from 3 to 0.78
lg/mL of n-Bu3Sn(HtpO2) (5), its organotin precursor
n-Bu3SnOCH3, and Ph3Sn(HtpO2) (6) (that showed
the best activity on C. albicans) and incubated at 37
C in shaking bath for 3 h. After this incubation time
we determined, by counting in a hematocytometer,
the number of cells with germ tube and we could calcu-
late the inhibition percentages by comparing the sample
with a drug-free growth control, but added with
maximum concentration of solvent used to dissolve
the substances, undergone to the same experimental
conditions.
2.3.5. Bioﬁlms susceptibility testing
C. albicans ATCC 10231 was cultivated in yeast
nitrogen base (YNB) medium (Sigma) with 50 mM glu-
cose at 37 C for 24 h. After this time it was diluted in
the same medium to an optical density of 0.8 at 520
nm. [9]. 100 lL of such suspension were inoculated in
wells of a 96-well plates at 37 C; after 24 h the wells
were washed three times with 200 lL of sterile phos-
phate-buﬀered saline (PBS). The plates were air dried
at 37 C and to each well, except in the case of positive
(growth) controls, 100 lL broth Sabouraud were added,
supplemented with concentrations ranging from 25 to
0.78 lg/mL, the MIC of n-Bu3Sn(HtpO2) determined
on planktonic form of the same strain. The plates were
incubated at 37 C for 24 h; after this incubation time
the medium was removed, the plates were air dried
and then each well was ﬁlled with 100 lL of PBS adding
20 lL of a 5 mg/mL MTT (methylthiazotetrazolium)
solution and incubated for 4 h at 37 C. The insoluble
purple formazan, obtained by cleavage of MTT made
by dehydrogenase enzymes of living cells, was dissolved
with a mixture of acidic isopropyl alcohol and Triton X-
100 (Sigma). The optical density of each well was read
by a microplate reader (ELX 800, Bio-Tek Instruments)
at 570 nm with background subtraction at 630 nm.
Comparison of optical density of positive control wells
with those of sample enabled the calculation of inhibi-
tion percentages of our substance at several
concentrations.
Biological activity data are reported in Tables 7 and 8
and in Fig. 5.
2.4. Quantum chemical calculations
DFT calculations, with full geometry optimization,
were performed on the 4,5,6,7-tetrahydro-5,7-dioxo-
[1,2,4]triazolo-[1,5a]-pyrimidine (H2tpO2) ligand, andon the two mono-anionic and on the di-anionic forms
(see Fig. 3), by the hybrid B3LYP method and using
the 6-31++G(D,P) basis set [10]. A vibration analysis
was performed within the harmonic approximation,
and the unscaled frequency values were compared with
the corresponding experimental data. A two layers
ONIOM calculation [11], with full geometry optimiza-
tion, was performed on two isomeric trans-di-n-butyl
octahedral model complexes of di-n-butyltin(IV) with
the tpO22 ligand, mimicking a truncated mono-dimen-
sional polymer with cis-O2 and trans-O2 coordination,
respectively (see Fig. 4). The DFT B3lyp level, with
the DZVP basis set [12], was used for the higher layer,
including the central di-n-butyltin moiety and the two
coordinated tpO22 ligands; the semiempirical AM1
method was used for the lower layer. To neutralize the
overall charge of the system, the external ligands were
considered monoanionic. All calculations were per-
formed by the Gaussian98 program package [13]. The
119Sn Mo¨ssbauer nuclear quadrupole splitting was cal-
culated by the calibration formula DEcalcd = 0.93 Æ V ±
0.58 mm s1 [14], where V ¼ V zz½1þ 13 ðV xxV yyV zz Þ
21=2 and
where Vxx, Vyy, Vzz, following the condition jVzzjP
jVyyjP jVxxj, are the eigenvalues of the diagonalized
electric ﬁeld gradient tensor, calculated at the same level
of theory of the higher layer [14].3. Results and discussion
3.1. 5HtpO derivatives
The most basic positions for the ligand in the molec-
ular or anionic form appear to be, on the basis of semi-
empirical [5] and ab initio calculations [15], N(3) and
N(4), respectively (Fig. 1).
X-ray structures of some transition metal complexes
show that in most cases the ligand, in his neutral enolic
or anionic form, bridges two metal ions through N(3),
N(4) atoms [16,4,17]; only two exceptions are known,
[Cu2(phen)2(5tpO)2(H2O)2](NO3)2 Æ 4H2O [16] where
5tpO bridges two Cu2+ ions through N(3) and O(5)
atoms, and [Ni(NCS)2(5HtpO)2 Æ (H2O)2] [18], charac-
terized by an all-trans octahedral structure with two
5HtpO ligands coordinated through the N atom in posi-
tion 3. The ionization of the ligand is normally associ-
ated to a shift of the m(C@O) absorption to lower
wavenumbers, while an extra-shift has been attributed
to the involvement of O(5) in coordination [16]. In fact,
in the above mentioned copper complex [16], where the
triazolopyrimidine ligand binds the copper ions through
N(3) and O(5), m(C@O) is at 1637 cm1, while in com-
plexes where the ligand is N(3), N(4) coordinated,
m(C@O) appears near 1650 cm1 [16].
In the Me3Sn(5tpO) and n-Bu3Sn(5tpO) complexes
the m(C@O) absorption is observed at 1627 cm1
Fig. 2. Proposed structure for R3SnL (R = Me, n-Bu, L = 5tpO
;
R = Me, L = mtpO; R = n-Bu, Ph, L ¼ HtpO2 ).
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oxygen in the bond (Table 3).
The 119Sn Mo¨ssbauer quadrupole splitting values, re-
ported in Table 1, allow us to make the following con-
siderations about the coordination geometry of
compounds 1 and 2: (i) tetrahedral species, originated
by unidentate ligand coordination, can be excluded on
the basis of the DE values, considerably larger than
those observed for compounds of such geometry (<3.2
mm s1, [19]); (ii) the coordination number of tin may
increase as a result of a bidentate, chelate or bridged
bis-unidentate, coordination. Chelation through N(4),
O(5) would be sterically favoured with respect to the
N(3), N(4) one (see Fig. 1), consistently with the remark-
able shift of the m(C@O) band. Two geometries would be
in this case formally possible, i.e., fac-R3 and mer-R3 tri-
gonal bipyramidal; in both cases a severely distorted
structure would be expected, due to the narrow bite an-
gle in the ligand. Assuming regular structures, the fac-R3
conﬁguration may be excluded, as the quadrupole split-
ting value would be considerably lower than that ob-
served, while it falls in the characteristic range for
mer-R3 tbp complexes (2.99–4.08 mm s
1 [19]). Actually,
the distortions introduced by the O\N (or, possibly,
N\N) chelation would preferentially give rise to a dis-
torted tetrahedron with a long, additional tin–ligand
bond [20] and a considerably lower quadrupole splitting
value [19].
As a result of the above considerations, the most reli-
able hypothesis is that the anionic ligand bridges two
R3Sn
IV units through O(5) and N(3) donor atoms. The
observed quadrupole splitting values fully agree with
such a structure. The geometry of the trimethyltin group
may be deduced from the tin–carbon stretching modes
which occur in the 550–500 cm1 region of the infrared
spectra. A trigonal-planar SnC3 structure (local D3h
symmetry) will give rise to infrared-active masym(Sn–C)
modes, but also the msym(Sn–C) mode will appear in
the spectrum if there is signiﬁcant deviation from pla-
narity. In the infrared spectrum of Me3Sn(5tpO) an in-
tense absorption at 557 cm1 can be attributed to
masym(Sn–C); a much less intense band, at 514 cm
1, is
diﬃcult to be attributed owing to the presence of many
ligand absorptions, while a q(CH3) intense band is pres-
ent at 774 cm1. Hence, the infrared spectra support the
hypothesis of the R3Sn group being planar or nearly pla-
nar in the proposed structure shown in Fig. 2.
3.2. HmtpO derivatives
The literature data relative to transition metal com-
plexes of HmtpO show a strong preference for the
N(3) coordination [21]. When the ligand is in the anionic
form, also a N(3),N(4) bridging coordination is ob-
served in dinuclear [22–25] or polynuclear complexes
[25]. Only in one case ([Cu(mtpO)2(1,3-propane di-amine)] Æ 2H2O, [21]) a N(1),O(7) chelation by mtpO

was reported while an O(7)–metal ion interaction was
observed in the complexes Ag(NO3)(HmtpO) (O(7)–
Ag = 2.69 A˚) [25], Ag3(HSO4)(mtpO)2 Æ 3H2O (O(7)–
Ag = 2.63 A˚) [25] and Ag(mtpO) (O(7)–Ag = 2.78 A˚)
[26]. The infrared spectra of the complexes with the
molecular form of the ligand (HmtpO), are generally
characterized by a 20 cm1 shift to high frequency
[27,21,28], but minimal changes were observed in some
cases, including the chelate complex Ag(NO3)(HmtpO)
[25,29], or a consistent shift to lower frequency [30,27].
On the other hand, a 30–60 cm1 shift to low frequency
seems to be associated to the deprotonation of HmtpO
[21,30]. The sole exception is the above mentioned cop-
per complex [21], whose infrared spectrum is character-
ized by a very small shift of the m(C@O) band, from 1700
to 1695 cm1.
The complexes Me3Sn(mtpO) (3) and n-Bu3Sn(mtpO)
(4) were obtained neutralizing the triorganotin(IV)
hydroxides with HmtpO and contain the ligand in the
deprotonated form. Their infrared spectra (Table 3) show
the expected shift to low frequency of the m(C@O) absorp-
tion band, associated with the ionization of the ligand:
m(C@O) = 1702, 1620 and 1633 cm1 for HmtpO,
Me3Sn(mtpO) and n-Bu3Sn(mtpO), respectively.
In the spectrum of Me3Sn(mtpO) an intense absorp-
tion at 546 cm1 may be attributed to the asymmetric
tin–carbon stretching, while no absorptions are present
which may be attributed to msym(Sn–C). That is consis-
tent with the presence of planar SnC3 groups bridged
by bis-monodentate mtpO units. Mo¨ssbauer data
(Table 1) support such hypothesis, the quadrupole split-
ting values being fully consistent with a trigonal bipyra-
midal structure (Fig. 2) with organic groups in the
equatorial plane and electronegative groups in axial po-
sition. Donor atoms would be N(3) and N(1), as in
{Ag(NO3)(l-HmtpO-j
2N1,N3)}n [25]. No evidence of a
possible Sn–O(7) interaction can be extracted from the
infrared spectra. A q(CH3) intense band is present at
775 cm1 in the infrared spectrum of Me3Sn(mtpO).
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The most stable tautomers of the ligand in the molec-
ular form (H2tpO2) and in its monoanionic ðHtpO2 Þ
and dianionic form ðtpO22 Þ, as derived from theoretical
calculations [6, this work] are shown in Fig. 3. The ﬁrst
ionization of the ligand involves the strongly acidic C(6)
methylene group (pKa1 = 2.9) [6], while the second ion-
ization (pKa2 = 9.9) concerns the N(4) hydrogen [6].
The infrared spectra of the ligand (Table 3) are char-
acterized by a strong, broad absorption due to stretch-
ing vibrations of both the carbonyl groups, centred at
1715, 1679 and 1644 cm1 in the spectra of H2tpO2,
NaHtpO2 and Na2tpO2, respectively.
The greater stability of the C(6) compared to the N(4)
ﬁrst deprotonation was conﬁrmed by our DFT calcula-
tions, showing that the HtpO2 isomer A is more stable,
of 31.9 kJ/mol, than HtpO2 B (see Fig. 3).
While the neutral and monoanionic form of the
H2tpO2 ligand have been previously characterized both
experimentally and by semi-empirical quantum chemical
calculations [6], the structure of the dianionic form has
not been up to date considered. Quite obviously, the
ring planarity is preserved in all the systems investigated.
The enolic character, hence the coordination strength
toward hard metals, of the oxygen hetero-atoms in-
creases by increasing the negative charge of the mole-
cule. This can be observed in Table 4, by considering
the increasing trend in the C–O bond length (of about
0.06 A˚) and, qualitatively, in the Mulliken negative
charge on the oxygen atoms, by going from H2tpO2 toFig. 3. Structures of the neutral, mono- and di-anionic H2tpO2 ligand,tpO22 . This result is also supported by the monotonous
lowering of the calculated IR frequency of the stretching
bands of the carbonyl groups (see Table 5), in agreement
with the experimental IR data relative to NaHtpO2,
Na2tpO2 and n-Bu2Sn(tpO2), compared to the isolated
ligand (see Table 3). Following the results of our calcu-
lations, this trend is to be attributable mainly to the
increasing of the enolic character of the carbonyl groups
following the deprotonations of the hydrogen atoms,
respectively, on C(6) and N(4).
A previous theoretical study [6] showed that the exo-
cyclic oxygens, O(7) and O(5), are the primary coordina-
tion sites for HtpO2 . The O(7),N(1) bidentate
coordination, supported by the formation of a ﬁve mem-
bered chelate ring, is, however, preferred to other possi-
ble coordination modes.
The O(7),N(1) coordination mode was observed in
[Mn(HtpO2)2(H2O)2] [31] where the ligand has a geom-
etry virtually identical to the one present in its sodium
salt. Its infrared spectrum is characterized by the pres-
ence of the carbonyl group stretching band at 1652
cm1. Comparing this value with that observed for
NaHtpO2, the m(C@O) shift seems rather to be deter-
mined by the ionization of the ligand, than by metal
coordination.
Triorganotin complexes, n-Bu3Sn(HtpO2) (5) and
Ph3Sn(HtpO2) (6), exhibit similar infrared spectra, with
the m(C@O) band centred at 1654 and 1661 cm1,
respectively. O(7),N(1) bidentate coordination can be,
however, ruled out on the basis of the 119Sn Mo¨ssbauer
quadrupole splitting values, which strongly suggestobtained after full geometry optimization at DFT level (see text).
Table 4
Geometrical parameters (bond distances, in A˚, and angles, in ) and
Mulliken charges (Q) (in a.u.) on selected atoms, calculated at DFT
level (see text) for the compounds shown in Fig. 3
H2tpO2 HtpO

2 A HtpO

2 B tpO
2
2
N(1)–C(2) 1.313 1.321 1.319 1.329
C(2)–N(3) 1.381 1.369 1.361 1.352
N(3)–C(3) 1.309 1.333 1.342 1.372
C(3)–N(8) 1.375 1.360 1.421 1.396
C(3)–N(4) 1.373 1.358 1.334 1.329
N(4)–C(5) 1.387 1.428 1.355 1.391
C(5)–O(5) 1.216 1.248 1.241 1.274
C(5)–C(6) 1.526 1.420 1.549 1.449
C(6)–C(7) 1.526 1.418 1.518 1.409
C(7)–O(7) 1.206 1.235 1.223 1.262
C(7)–N(8) 1.409 1.462 1.380 1.432
N(1)–N(8) 1.381 1.375 1.389 1.383
N(1)–C(2)–N(3) 116.4 116.7 118.1 118.0
C(2)–N(3)–C(3) 101.9 101.2 103.7 102.8
N(3)–C(3)–N(8) 111.2 111.3 107.2 107.6
C(3)–N(4)–C(5) 123.7 122.8 118.1 116.8
N(4)–C(5)–C(6) 116.1 115.1 120.2 119.2
C(5)–C(6)–C(7) 120.2 125.9 119.4 125.1
C(6)–C(7)–N(8) 113.3 112.0 112.2 111.0
C(7)–N(8)–C(3) 125.7 124.5 124.5 122.9
C(3)–N(8)–N(1) 108.6 108.9 110.2 110.7
N(8)–N(1)–C(2) 101.9 101.9 100.8 100.9
QN(1) 0.21 0.36 0.32 0.42
QN(3) 0.33 0.40 0.36 0.39
QN(4) 0.46 0.54 0.49 0.55
QO(5) 0.44 0.63 0.54 0.69
QO(7) 0.40 0.59 0.50 0.70
QN(8) 0.11 0.11 0.08 0.09
Table 5
IR carbonyl bands (cm1) calculated for the neutral, mono- and di-
anionic H2tpO2 ligand
m(C(7)O(7)) m(C(5)O(5))
H2tpO2 1837 1796
HtpO2 A 1730 1693
tpO22 1651 1557
1546
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equatorial position. In particular, the Mo¨ssbauer
parameters of n-Bu3Sn(HtpO2) (d = 1.48; DE = 3.90
mm s1) are very similar to those of tri-n-butyltin 2-
[(E)-2-(2-hydroxy-5-methylphenyl)-1-diazenyl]benzoate
[32] (d = 1.50; DE = 3.85 mm s1), characterized by a
distorted trigonal bipyramidal trans-R3SnO2 geometry
with non-equivalent Sn–O bonds. Taking into account
the diﬀerent electron donor character of alkyl- and
aryl-groups, the complexes n-Bu3Sn(HtpO2) and
Ph3Sn(HtpO2) appear to be isostructural on the base
of the Mo¨ssbauer parameters. According to the base
character of the ligand donor atoms we can reasonably
hypothesize a trans-O2 R3SnO2 structure for our com-
plexes, HtpO2 bridging tin centres through O(7) and
O(5) (see Fig. 2). Calculations of quadrupole splittingsbased on the point-charge formalism [33], attributing
to the ligand a pqs = 0.13 mm s1, derived by Bancroft
[34] for O-coordinated dimethylformamide, give QScalc
values of 3.91 mm s1 for Alj3Sn(HtpO2) and of 3.46
mm s1 for Ph3Sn(HtpO2), which agree with the exper-
imental data (see Table 1). It is worth to note that the
O(7)–N(1) chelation would give a fac-R3 trigonal bipy-
ramidal structure with a remarkably lower quadruple
splitting. On the other hand, the polymeric nature of
the products is supported by the circumstance that
Ph3Sn(HtpO2) exhibits an observable Mo¨ssbauer spec-
trum at room temperature.
Further evidences would in principle be deduced from
the infrared spectra, on the basis, e.g., of tin–carbon
stretching frequencies; unfortunately, due to the pres-
ence of many bands, it is not possible to assign with cer-
tainty the absorptions relative to tin–ligand vibrations.
However, in the spectrum of the triphenyltin(IV) deriv-
ative 6, following Kriegsmann and Geissler [35], we can
attribute to phenyl group vibrations the bands at 1481 m
and 1430 m (m(C–C)), at 1078m (b(C–H)), at 727s and
697s (c(C–H)) [35].
Our structural hypotheses seem probable on the basis
of the nature of the ligand and the chemistry of triorg-
anotins and is fully supported by Mo¨ssbauer data.
The triorganotin derivatives 5 and 6, selected for the
biological tests (see Section 3.4, antimicrobial activity)
were also characterized in solution phase by means of
13C NMR and 119Sn Mo¨ssbauer spectroscopy. Owing
to the low solubility in water, methanol solutions were
employed; the tributyltin derivative, being considerably
soluble, produced good NMR and Mo¨ssbauer spectra,
while only satisfactory Mo¨ssbauer spectra (on the frozen
saturated solution) were obtained for Ph3Sn(HtpO2).
The scarce solubility of 6 obviously didnt aﬀect the bio-
logical assays, very little amounts of drug being re-
quested (see experimental section). The spectral data in
solution phase are reported in Table 2. The 13C NMR
spectrum of n-Bu3Sn(HtpO2) conﬁrms the composition
of the complex, and the value of the coupling constant
j1J(13C–119Sn)j, 454.5 Hz, indicates that the C3Sn unit
maintains in methanol solution the same geometry as-
sumed by the complex in the solid state, the C–Sn–C an-
gle being 120 [36]. The same conclusion may be
extracted, on the other hand, from the Mo¨ssbauer spec-
trum on the frozen solution, the hyperﬁne parameters
being fully consistent with those relative to the solid
state complex (see Tables 1 and 2). The Mo¨ssbauer data
show also that the triphenyltin derivative maintains the
trigonal bipyramidal structure in methanol solution. In
order to evaluate if the complex is stable in aqueous
solution, the Mo¨ssbauer spectrum of a frozen metha-
nol/aqueous solution (2:1) of 5 was measured; as shown
in Table 2, the Mo¨ssbauer parameters still fully agree
with those relative to the solid state complex. We can
conclude that the complexes tested for biological activity
4780 M.A. Girasolo et al. / Journal of Organometallic Chemistry 690 (2005) 4773–4783maintain in solution the same structure they have in the
solid state.
The diorganotin derivative, n-Bu2Sn(tpO2) (7) was
obtained reacting n-Bu2SnO with H2tpO2 (in 1:1 and
1:2 ratios), or n-Bu2Sn(OMe)2 with H2tpO2 (1:1 ratio).
In any case a compound is obtained whose Mo¨ssbauer
spectrum is characterized by a very wide doublet (DE-
mean = 4.44 mm s
1; Cmean = 0.91 mm s
1) typical of
trans-R2 octahedral structures. The complex exhibits ob-
servable Mo¨ssbauer spectrum at room temperature sug-
gesting a polymeric nature. On the other hand,
considering the stoichiometry of the compound, only a
polymeric structure would justify the observed nuclear
quadrupole splitting, as only a bridged coordination of
the ligand would allow an octahedral arrangement of li-
gand atoms around tin.
A trans-R2 octahedral structure implies that the li-
gand chelates two organotin(IV) moieties. A donor
atoms couple would be obviously O(7)–N(1), while the
other one could be either O(5)–N(4) or N(4)–N(3).
Moreover, there is a consequent ambiguity about the
mutual disposition of the chelating ligands in the equa-Fig. 4. Calculated structures, by a two layers ONIOM method (see text), of
the dibutyltin(IV) with tpO22 , n-Bu2Sn(tpO2)_A and n-Bu2Sn(tpO2)_B, showtorial plane. The infrared spectrum of the complex show
a strong, broad band centred at 1629 cm1 (see Table 3)
attributable to carbonyl stretching frequencies. The ob-
served shift is consistent with the presence of the dian-
ionic form of the ligand, tpO22 .
With the aim to explain the experimental results in
terms of structural properties of this complex, quantum
chemical calculations by the ONIOM method have been
performed on two model systems of the polymeric
n-Bu2Sn(tpO2) complex, shown in Fig. 4. The two
isomeric trans-n-Bu2 octahedral structures, n-Bu2Sn-
(tpO2)_A and n-Bu2Sn(tpO2)_B in Fig. 4, involve the
N(1), O(7) and N(4), O(5) bis-chelate coordination,
with, respectively, cis-O2 and trans-O2 disposition of
the equatorial ligands.
Preliminary DFT calculations performed on the
n-Bu2SnðtpO2Þ22 anion allowed us to rule out the possi-
ble chelating coordination through the atoms N(4),
N(3). In fact, the two corresponding structures were
more than 60 kJ/mol less stable than the structure of
lowest energy minimum found, i.e., the one with the
coordination observed for n-Bu2Sn(tpO2)_A.two isomeric model systems of the trans-dibutyl octahedral complex of
ing cis-O2 and trans-O2 coordination, respectively.
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ered (see Fig. 4), the cis-O2 coordination, corresponding
to n-Bu2Sn(tpO2)_A, is more stable of about 18 kJ/mol
compared to the trans-O2 coordination, corresponding
to n-Bu2Sn(tpO2)_B. Moreover, the calculated nuclear
quadrupole splitting value relative to n-Bu2Sn(tpO2)_A
is in much better agreement with the experimental value
of DE, compared to the one calculated for n-Bu2Sn-
(tpO2)_B (see Table 6). These results strongly support
the hypothesis of trans-di-n-butyl, cis-O2 distorted octa-
hedral coordination geometry for the investigated
compound.
A further support to such coordination geometry also
comes from the polymeric structure obtained in the solid
state for the complex NaHtpO2 [6]. The X-ray crystallo-
graphic analysis showed the involvement of a similar
coordination of the metal atom through N(1), O(7),
O(5) and of the protonated N(4) atom through hydro-
gen bond to a coordinated water molecule. It is probable
that the hard character of sodium and tin(IV) leads to
the preferential coordination of the highly negatively
charged oxygen atoms compared to the N(3) atom.Table 6
Relevant geometrical parameters (bond distances, in A˚, and angles,
in ) relative to the central tin environment of the two isomer model
systems, n-Bu2Sn(tpO2)_A and n-Bu2Sn(tpO2)_B, shown in Fig. 4,
calculated by a two layer ONIOM method (see text). Their relative
energy and the calculated nuclear quadrupole splitting values are also
reported
n-Bu2Sn(tpO2)_A n-Bu2Sn(tpO2)_B
Sn–C (average) 2.175 2.173
Sn–N(1) 2.299 2.701
Sn–O(7) 2.411 2.161
Sn–N(4) 2.325 2.249
Sn–O(5) 2.412 2.412
C(5)–O(5) 1.271 1.289
C(7)–O(7) 1.269 1.273
C–Sn–C 150.7 142.8
N(1)–Sn–O(7) 71.4 68.7
N(1)–Sn–O(5) 147.3 150.7
N(1)–Sn–N(4) 90.9 152.2
N(4)–Sn–O(5) 56.5 57.1
N(4)–Sn–O(7) 162.2 83.5
O(5)–Sn–O(7) 141.3 140.4
Energy (kJ/mol) 0.0 18.5
DEcalcd (mm s
1) 4.15 3.78
Table 7
Antimicrobial activity in vitro, MIC values in lg/mL
Compound E. coli
ATCC25922
P. aeruginosa
ATCC9027
S. a
AT
n-Bu3SnOCH3 >100 >100 >10
5 n-Bu3Sn(HtpO2) >100 100 1
Ph3SnOH >100 >100 >10
6 Ph3Sn(HtpO2) >25 >25
Amikacin 10 5
Amphotericin B3.4. Antimicrobial activity
n-Bu3Sn(HtpO2) and Ph3Sn(HtpO2), 5 and 6, and their
organotin precursors n-Bu3SnOCH3 and Ph3SnOH, were
screened for their in vitro antimicrobial activity on a
group of representative Gram-positive, Gram-negative
bacteria and on two human pathogen fungal strains.
The antimicrobial activities of the substances, expressed
as minimum inhibitory concentration, are reported in
Table 7.
A good activity (MIC equal to 3.1 lg/mL) against S.
epidermidis is exhibited by 5 better than the parent
organotin(IV) compound, n-Bu3SnOCH3.
6 possessed a good activity as anti Gram positive
while its parent Ph3SnOH resulted inactive at the maxi-
mum tested concentration. We also observed a good
antifungal activity for 6, with MIC values of 0.78
against both strains of C. albicans and C. tropicalis.
A good antifungal activity was also shown by n-
Bu3Sn(HtpO2) (5), with MIC values of 0.78 and 1.5
lg/mL against C. albicans and C. tropicalis, respectively,
although its organotin precursor n-Bu3SnOCH3 resulted
equally active against C. albicans and with a slight better
activity against C. tropicalis (MIC 0.78 lg/mL).
C. albicans is an opportunistic pathogen with a great
capacity to pass from commensalisms to virulence; in
this transition the formation of germ tube is a key fea-
ture [37], so we extended our investigation by examining
the anti-germ tube formation eﬀect of derivatives n-
Bu3Sn(HtpO2) (5), n-Bu3SnOCH3 and Ph3Sn(HtpO2)
(6) at concentrations equal to MIC, 2 ·MIC and
4 ·MIC. The germ-tube inhibition is summarized in Ta-
ble 8. n-Bu3Sn(HtpO2) possesses a signiﬁcant activity at
concentrations of 3 and 1.5 lg/mL, corresponding to
4 ·MIC and 2 ·MIC, respectively, but a lower activity
at 0.78 lg/mL, equal to MIC. Its organotin precursor n-
Bu3SnOCH3 showed an interesting activity also at MIC
concentration of 0.78 lg/mL, while Ph3Sn(HtpO2) re-
sulted not eﬀective as anti germ-tube formation at
MIC concentration.
The germ tube formation is a virulence factor that
plays a role in the formation of bioﬁlms of C. albicans
too [38]. Hence, the antibioﬁlm properties of n-
Bu3Sn(HtpO2) have been also tested, at concentrations
ranging from 25 to 0.78 lg/mL, against a preformedureus
CC25923
S. epidermidis
DSM 3269
C. albicans
ATCC10231
C. tropicalis
ATCC13803
0 >100 0.78 0.78
2.5 3.1 0.78 1.5
0 >100 >100 >100
6.2 3.1 0.78 0.78
1 0.62
0.15 0.31
Table 8
Inhibition of germ tube formation in C. albicans ATCC 10231
Compound Concentration
4 ·MIC 2 ·MIC MIC
5 n-Bu3Sn(HtpO2) 92.1 ± 0.7 90 ± 5 35.1 ± 0.7
6 Ph3Sn(HtpO2) 83 ± 4 35 ± 5 ns
n-Bu3SnOCH3 85 ± 3 75 ± 3 68 ± 2
ns: not signiﬁcant; the values are the mean of at least three independent
determinations; coeﬃcient of variation was less than 15%.
Fig. 5. In vitro inhibition percentages on C. albicans ATCC10231
bioﬁlm by n-Bu3Sn(HtpO2) (5). Values are the average of at least three
independent determinations. Coeﬃcient of variation was less than
15%.
4782 M.A. Girasolo et al. / Journal of Organometallic Chemistry 690 (2005) 4773–4783bioﬁlm of C. albicans. Although the MIC value was
good against the planktonic form of C. albicans, we re-
ported a weak activity at concentration equal to MIC
against bioﬁlm of the same strain, in fact we only ob-
served an interesting antibioﬁlm eﬀect at concentrations
16 ·MIC or more (see Fig. 5).
Candida albicans infections often involve the forma-
tion of bioﬁlms on implanted devices or on tissue sur-
faces, such infections are diﬃcult to treat, because
bioﬁlms are resistant to a wide range of current anti-
fungal agents [39]. There is therefore an urgent need to
develop new agents and we think that n-Bu3Sn(HtpO2)
might represent a lead compound for developing anti-
fungal and antibioﬁlm agents.Acknowledgment
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